litlas
Log inCreate account

Daniel G. Anderson

Active 1997–2025

240
Papers
70,139
Citations
139
h-index
233
i10-index

Citations

Citations per year for Daniel G. Anderson1990: 2 citations1994: 4 citations1998: 9 citations1999: 5 citations2000: 10 citations2001: 9 citations2002: 12 citations2003: 19 citations2004: 25 citations2005: 67 citations2006: 93 citations2007: 109 citations2008: 165 citations2009: 220 citations2010: 286 citations2011: 378 citations2012: 466 citations2013: 442 citations2014: 646 citations2015: 793 citations2016: 986 citations2017: 1,095 citations2018: 1,462 citations2019: 3,106 citations2020: 3,555 citations2021: 3,849 citations2022: 3,279 citations2023: 3,159 citations2024: 4,080 citations2025: 2,461 citations2026: 97 citations1991–1993: no citations, so these years are not shown1995–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,376 citing papers, 26.2% of this breakdownChina: 6,014 citing papers, 21.3% of this breakdownUnited Kingdom: 1,169 citing papers, 4.1% of this breakdownGermany: 1,151 citing papers, 4.1% of this breakdownSouth Korea: 854 citing papers, 3% of this breakdownIndia: 847 citing papers, 3% of this breakdownCanada: 752 citing papers, 2.7% of this breakdownAustralia: 702 citing papers, 2.5% of this breakdownJapan: 668 citing papers, 2.4% of this breakdownItaly: 659 citing papers, 2.3% of this breakdownFrance: 599 citing papers, 2.1% of this breakdownNetherlands: 589 citing papers, 2.1% of this breakdown
0%26.2%Other 24.2%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology50.3%
  • Medicine19.4%
  • Engineering8.1%
  • Materials Science7.7%
  • Immunology and Microbiology7.5%
  • Pharmacology, Toxicology and Pharmaceutics2.6%
  • Other4.4%

Topics

  • RNA Interference and Gene Delivery11.3%
  • Advanced biosensing and bioanalysis techniques6.6%
  • CRISPR and Genetic Engineering3.6%
  • Nanoparticle-Based Drug Delivery3.1%
  • Immunotherapy and Immune Responses2.5%
  • Virus-based gene therapy research2.5%
  • Other70.4%

Coauthors

All papers

Open in search
  1. The clinical progress of mRNA vaccines and immunotherapies

    Authors: Ann Barbier, Allen Yujie Jiang, Peng Zhang, Richard Wooster, Daniel G. Anderson - Nature Biotechnology 2022 cited by 770

  2. Non-viral vectors for gene-based therapy

    Authors: Hao Yin, Rosemary Kanasty, Ahmed A. Eltoukhy, Arturo J. Vegas, J. Robert Dorkin, Daniel G. Anderson - Nature Reviews Genetics 2014 cited by 3,079

  3. CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling

    Authors: Randall J. Platt, Sidi Chen, Yang Zhou, Michael J. Yim, Lukasz Swiech, H. Kempton, James E. Dahlman, Oren Parnas, Thomas Eisenhaure, Marko Jovanović, D. B. Graham, Siddharth Jhunjhunwala, Matthias Heidenreich, Ramnik J. Xavier, Robert Langer, Daniel G. Anderson, Nir Hacohen, Aviv Regev, Guoping Feng, Phillip A. Sharp, Feng Zhang - Cell 2014 cited by 2,087

  4. Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery

    Authors: Piotr S. Kowalski, Arnab Rudra, Lei Miao, Daniel G. Anderson - Molecular Therapy 2019 cited by 1,086

  5. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation

    Authors: Lei Miao, Linxian Li, Yuxuan Huang, Derfogail Delcassian, Jasdave S. Chahal, Jinsong Han, Yunhua Shi, Kaitlyn Sadtler, Wenting Gao, Jiaqi Lin, Joshua C. Doloff, Róbert Langer, Daniel G. Anderson - Nature Biotechnology 2019 cited by 701

  6. Engineering circular RNA for potent and stable translation in eukaryotic cells

    Authors: R. Alexander Wesselhoeft, Piotr S. Kowalski, Daniel G. Anderson - Nature Communications 2018 cited by 840

  7. Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs

    Authors: Kevin Kauffman, J. Robert Dorkin, Jung Hoon Yang, Michael W. Heartlein, Frank DeRosa, Faryal F. Mir, Owen S. Fenton, Daniel G. Anderson - Nano Letters 2015 cited by 768

  8. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing

    Authors: Bowen Li, Rajith S. Manan, Shun‐Qing Liang, Akiva G. R. Gordon, Allen Yujie Jiang, Andrew Varley, Guangping Gao, Róbert Langer, Wen Xue, Daniel G. Anderson - Nature Biotechnology 2023 cited by 274

  9. Knocking down barriers: advances in siRNA delivery

    Authors: Kathryn A. Whitehead, Róbert Langer, Daniel G. Anderson - Nature Reviews Drug Discovery 2009 cited by 3,113

  10. Delivery materials for siRNA therapeutics

    Authors: Rosemary Kanasty, J. Robert Dorkin, Arturo J. Vegas, Daniel G. Anderson - Nature Materials 2013 cited by 1,782

  11. Strategies, design, and chemistry in siRNA delivery systems

    Authors: Yizhou Dong, Daniel J. Siegwart, Daniel G. Anderson - Advanced Drug Delivery Reviews 2019 cited by 573

  12. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity

    Authors: Kathryn A. Whitehead, J. Robert Dorkin, Arturo J. Vegas, Philip Chang, Omid Veiseh, J. Matthews, Owen S. Fenton, Yunlong Zhang, Karsten Olejnik, Volkan Yesilyurt, Delai Chen, Scott Barros, Boris Klebanov, Tatiana I. Novobrantseva, Róbert Langer, Daniel G. Anderson - Nature Communications 2014 cited by 617

  13. RNA Circularization Diminishes Immunogenicity and Can Extend Translation Duration In Vivo

    Authors: R. Alexander Wesselhoeft, Piotr S. Kowalski, Frances C. Parker-Hale, Yuxuan Huang, Namita Bisaria, Daniel G. Anderson - Molecular Cell 2019 cited by 464

  14. Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver

    Authors: Lei Miao, Jiaqi Lin, Yuxuan Huang, Linxian Li, Derfogail Delcassian, Yifan Ge, Yunhua Shi, Daniel G. Anderson - Nature Communications 2020 cited by 333

  15. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy

    Authors: Matthias A. Oberli, Andreas M. Reichmuth, J. Robert Dorkin, Michael J. Mitchell, Owen S. Fenton, Ana Jaklenec, Daniel G. Anderson, Róbert Langer, Daniel Blankschtein - Nano Letters 2016 cited by 702

  16. Lipid-like materials for low-dose, in vivo gene silencing

    Authors: Kevin T. Love, Kerry P. Mahon, Christopher G. Levins, Kathryn A. Whitehead, William Querbes, J. Robert Dorkin, June Qin, William Cantley, Liu Liang Qin, Timothy Racie, Maria Frank-Kamenetsky, Ka Ning Yip, Rene Alvarez, Dinah W.Y. Sah, Antonin de Fougerolles, Kevin Fitzgerald, Victor Koteliansky, Akin Akinc, Róbert Langer, Daniel G. Anderson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 965

  17. Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium

    Authors: Asha K. Patel, James C. Kaczmarek, Suman Bose, Kevin Kauffman, Faryal F. Mir, Michael W. Heartlein, Frank DeRosa, Robert Langer, Daniel G. Anderson - Advanced Materials 2019 cited by 374

  18. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

    Authors: Akin Akinc, Andreas Zumbuehl, Michael S. Goldberg, Elizaveta S. Leshchiner, Valentina Busini, Naushad Hossain, Sergio Bacallado, David N. Nguyen, Jason Fuller, Rene Alvarez, Anna Borodovsky, Todd Borland, Rainer Constien, Antonin de Fougerolles, J. Robert Dorkin, K. N. Jayaprakash, Muthusamy Jayaraman, Matthias John, Victor Koteliansky, Muthiah Manoharan, Lubomir V. Nechev, June Qin, Timothy Racie, Denitza Raitcheva, Kallanthottathil G. Rajeev, Dinah W.Y. Sah, Jürgen Soutschek, Ivanka Toudjarska, Hans‐Peter Vornlocher, Tracy Zimmermann, Róbert Langer, Daniel G. Anderson - Nature Biotechnology 2008 cited by 1,220

  19. Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry

    Authors: Bowen Li, Idris O. Raji, Akiva G. R. Gordon, Lizhuang Sun, Theresa M. Raimondo, Favour A. Oladimeji, Allen Yujie Jiang, Andrew Varley, Róbert Langer, Daniel G. Anderson - Nature Materials 2024 cited by 187

  20. Combinatorial development of nebulized mRNA delivery formulations for the lungs

    Authors: Allen Yujie Jiang, Jacob Witten, Idris O. Raji, Feyisayo Eweje, Corina MacIsaac, Sabrina Meng, Favour A. Oladimeji, Yizong Hu, Rajith S. Manan, Róbert Langer, Daniel G. Anderson - Nature Nanotechnology 2023 cited by 162

  21. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics

    Authors: James E. Dahlman, Kevin Kauffman, Yiping Xing, Taylor E. Shaw, Faryal F. Mir, Chloe C. Dlott, Róbert Langer, Daniel G. Anderson, Eric T. Wang - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 323

  22. Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA

    Authors: Bowen Li, Allen Yujie Jiang, Idris Raji, Caroline Atyeo, Theresa M. Raimondo, Akiva G. R. Gordon, Luke H. Rhym, Tahoura Samad, Corina MacIsaac, Jacob Witten, Haseeb Mughal, Taras M. Chicz, Yue Xu, Ryan P. McNamara, Sangeeta N. Bhatia, Galit Alter, Róbert Langer, Daniel G. Anderson - Nature Biomedical Engineering 2023 cited by 149

  23. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery

    Authors: Hyukjin Lee, Abigail K. R. Lytton‐Jean, Yi Chen, Kevin T. Love, Angela I. Park, Emmanouil D. Karagiannis, Alfica Sehgal, William Querbes, Christopher Zurenko, Muthusamy Jayaraman, Chang G. Peng, Klaus Charissé, Anna Borodovsky, Muthiah Manoharan, Jessica Donahoe, Jessica Truelove, Matthias Nahrendorf, Róbert Langer, Daniel G. Anderson - Nature Nanotechnology 2012 cited by 1,172

  24. Synthesis and Biological Evaluation of Ionizable Lipid Materials for the In Vivo Delivery of Messenger RNA to B Lymphocytes

    Authors: Owen S. Fenton, Kevin Kauffman, James C. Kaczmarek, Rebecca L. McClellan, Siddharth Jhunjhunwala, Mark W. Tibbitt, Manhao D. Zeng, Eric A. Appel, J. Robert Dorkin, Faryal F. Mir, Jung Hoon Yang, Matthias A. Oberli, Michael W. Heartlein, Frank DeRosa, Róbert Langer, Daniel G. Anderson - Advanced Materials 2017 cited by 282